Related Experiment Video
Updated: Oct 5, 2025
07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
37.1K
[Expert consensus on preimplantation genetic testing for spinal muscular atrophy]
The Expert Consensus Group For Preimplantation Genetic Testing For Spinal Muscular Atrophy1, Liying Yan, Xiaohui Zhu
1Reproductive Medicine Center, Peking University Third Hospital, Beijing 100083, China. jie.qiao@263.net.
Summary
Spinal muscular atrophy (SMA), a severe pediatric neuromuscular disease, can be prevented using preimplantation genetic testing (PGT). This consensus standardizes PGT technologies to guide clinical application and prevent affected births.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Spinal muscular atrophy (SMA) is a frequent, fatal autosomal recessive pediatric neuromuscular disorder.
- It causes progressive muscle weakness and atrophy, impacting the trunk and limbs.
- High carrier frequency necessitates effective prevention strategies.
Purpose of the Study:
- To standardize preimplantation genetic testing (PGT) technologies for spinal muscular atrophy (SMA).
- To provide expert consensus guidance for the clinical application of PGT in SMA prevention.
Main Methods:
- Multidisciplinary expert discussion involving neurology, pediatrics, and reproductive genetics.
- Drafting of a consensus document based on current PGT technologies and clinical insights.
Main Results:
- A standardized approach to PGT for SMA has been established.
- Guidelines are provided for the effective clinical application of PGT to prevent SMA births.
Conclusions:
- Preimplantation genetic testing (PGT) offers an effective method for preventing the birth of children with spinal muscular atrophy (SMA).
- This consensus aims to ensure consistent and effective use of PGT technologies in clinical practice for SMA.
- Standardized PGT protocols are crucial for managing genetic neuromuscular diseases like SMA.
